Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Haas

Showing results (501-510 of 969) with videos related to

Pageof 97
Sort By:
Drug Safety|July 7, 2012
Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care settingJennifer S Haas, Mary Amato, Lucas Marinacci, et al.
Cancer Causes & Control : CCC|December 4, 2004
Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States)David A Haggstrom, Kathryn A Phillips, Su-Ying Liang, et al.
Journal of General Internal Medicine|April 6, 2004
Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk?Jennifer S Haas, Celia P Kaplan, Steven E Gregorich, et al.
Preventive Medicine|May 27, 2005
Factors affecting breast cancer risk reduction practices among California physiciansCelia Patricia Kaplan, Jennifer S Haas, Eliseo J Pérez-Stable, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2022
A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in GermanyHartmut Link, Stephen F Thompson, Marc Tian, et al.
Clinical Endocrinology|August 16, 2012
Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality?Christian S Haas, Inga Pohlenz, Ulrich Lindner, et al.
Thrombosis Research|April 4, 1998
Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of plateletsW P Jeske, J M Walenga, E Szatkowski, et al.
NDT Plus|May 19, 2015
Progressive renal insufficiency, hypercalcaemia, bicytopaenia and a history of breast cancerSebastian Letterer, Ulrich Lindner, Heinz-Wolfram Bernd, et al.
Breast Cancer Research and Treatment|June 18, 2011
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of careJennifer S Haas, Su-Ying Liang, Michael J Hassett, et al.
World Journal of Surgery|April 1, 1986
Complications of radiation therapy and factors in their preventionJ D Cox, R W Byhardt, J F Wilson, et al.
Pageof 97

Showing results (501-510 of 969) with videos related to

Sort By:
Pageof 97
Drug Safety|July 7, 2012
Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care settingJennifer S Haas, Mary Amato, Lucas Marinacci, et al.
Cancer Causes & Control : CCC|December 4, 2004
Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States)David A Haggstrom, Kathryn A Phillips, Su-Ying Liang, et al.
Journal of General Internal Medicine|April 6, 2004
Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk?Jennifer S Haas, Celia P Kaplan, Steven E Gregorich, et al.
Preventive Medicine|May 27, 2005
Factors affecting breast cancer risk reduction practices among California physiciansCelia Patricia Kaplan, Jennifer S Haas, Eliseo J Pérez-Stable, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2022
A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in GermanyHartmut Link, Stephen F Thompson, Marc Tian, et al.
Clinical Endocrinology|August 16, 2012
Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality?Christian S Haas, Inga Pohlenz, Ulrich Lindner, et al.
Thrombosis Research|April 4, 1998
Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of plateletsW P Jeske, J M Walenga, E Szatkowski, et al.
NDT Plus|May 19, 2015
Progressive renal insufficiency, hypercalcaemia, bicytopaenia and a history of breast cancerSebastian Letterer, Ulrich Lindner, Heinz-Wolfram Bernd, et al.
Breast Cancer Research and Treatment|June 18, 2011
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of careJennifer S Haas, Su-Ying Liang, Michael J Hassett, et al.
World Journal of Surgery|April 1, 1986
Complications of radiation therapy and factors in their preventionJ D Cox, R W Byhardt, J F Wilson, et al.
Pageof 97